Abstract
Areca nut is known a carcinogen for oral cancer in southeast Asia, however, the molecular mechanism leading to the malignancy is still unclear. To mimic the habit of areca nut chewing, our laboratory has established four oral cancer cell sublines (SAS, OECM1, K2, C9), chronically trained by areca nut extract (ANE). To elucidate the molecular basis of areca nut induced oral carcinogenesis, the differential proteomes between oral cancer cells and the ANE sublines were determined using the technique of isobaric mass tag (iTRAQ) labeling and multidimensional liquid chromatography-mass spectrometry (LC-MS/MS). Over thousand proteins were identified in four sublines, in which 194 proteins were found differential expressions in at least two ANE sublines. Bioinforatmic analysis revealed that these proteins participate in several pathways, with the regulation of epithelial to mesenchymal transition (EMT) most prominent. Fourteen proteins were confirmed differential expression in the ANE sublines, including Krt17. To shed more light on the mechanism of ANE induced carcinogenesis, Krt17 was further investigated. Knockdown Krt17 significantly suppressed ANE-induced cell growth, migration, and cell invasion, along with the modulation of EMT process. Furthermore, in a carcinogeninduced oral cancer mice model by 4NQO/arecoline, an active compound of ANE, Krt17 was found significantly up-regulated in all hyperplasia and carcinoma (p<0.001). In conclusion, we have identified proteome associated with chronic areca nut exposure in oral cancer cells. Krt17 was demonstrated contributing to areca nut induced oral malignancy. This study should attribute to risk assessment, disease prevention or other clinical applications of areca nut-induced oral cancer. 
